Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

Return on Capital (ROC)

Microsoft Excel

Return on Invested Capital (ROIC)

Shockwave Medical Inc., ROIC calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1 170,498 122,053 (7,113) (64,111) (49,755)
Invested capital2 672,462 318,057 174,255 91,274 158,673
Performance Ratio
ROIC3 25.35% 38.37% -4.08% -70.24% -31.36%
Benchmarks
ROIC, Competitors4
Abbott Laboratories 8.87% 10.96% 11.30% 8.01% 6.47%
Cigna Group 5.63% 8.53% 6.88% 9.84% 6.50%
CVS Health Corp. 7.17% 3.13% 7.01% 6.63% 5.97%
Elevance Health Inc. 9.35% 10.17% 11.14% 8.67% 9.75%
Humana Inc. 9.02% 10.50% 10.35% 17.73% 16.04%
Intuitive Surgical Inc. 22.30% 22.01% 37.63% 25.62% 42.29%
Medtronic PLC 5.89% 7.02% 5.59% 6.20% 7.51%
UnitedHealth Group Inc. 14.59% 13.68% 13.51% 13.84% 13.91%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 NOPAT. See details »

2 Invested capital. See details »

3 2023 Calculation
ROIC = 100 × NOPAT ÷ Invested capital
= 100 × 170,498 ÷ 672,462 = 25.35%

4 Click competitor name to see calculations.

Performance ratio Description The company
ROIC A measure of the periodic, after tax, cash-on-cash yield earned in the business. Shockwave Medical Inc. ROIC improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023.

Decomposition of ROIC

Shockwave Medical Inc., decomposition of ROIC

Microsoft Excel
ROIC = OPM1 × TO2 × 1 – CTR3
Dec 31, 2023 25.35% = 25.29% × 1.09 × 92.33%
Dec 31, 2022 38.37% = 25.51% × 1.54 × 97.68%
Dec 31, 2021 -4.08% = -2.64% × 1.36 × 100.00%
Dec 31, 2020 -70.24% = -93.91% × 0.74 × 100.00%
Dec 31, 2019 -31.36% = -115.00% × 0.27 × 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating profit margin (OPM). See calculations »

2 Turnover of capital (TO). See calculations »

3 Effective cash tax rate (CTR). See calculations »

The primary reason for the decrease in return on invested capital (ROIC) over 2023 year is the decrease in efficiency measured by turnover of capital (TO) ratio.


Operating Profit Margin (OPM)

Shockwave Medical Inc., OPM calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1 170,498 122,053 (7,113) (64,111) (49,755)
Add: Cash operating taxes2 14,167 2,898 847 453 390
Net operating profit before taxes (NOPBT) 184,665 124,951 (6,266) (63,658) (49,365)
 
Revenue 730,230 489,733 237,146 67,789 42,927
Profitability Ratio
OPM3 25.29% 25.51% -2.64% -93.91% -115.00%
Benchmarks
OPM, Competitors4
Abbott Laboratories 16.84% 20.24% 20.37% 16.05% 14.97%
Cigna Group 3.57% 5.39% 4.69% 7.72% 5.38%
CVS Health Corp. 3.82% 2.45% 4.32% 4.79% 4.69%
Elevance Health Inc. 5.39% 5.61% 6.54% 6.03% 6.47%
Humana Inc. 3.64% 4.33% 4.49% 6.64% 5.73%
Intuitive Surgical Inc. 28.14% 26.19% 33.56% 28.14% 34.15%
Medtronic PLC 19.63% 19.15% 16.48% 17.88% 22.11%
UnitedHealth Group Inc. 9.14% 9.13% 8.33% 9.15% 8.41%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2023 Calculation
OPM = 100 × NOPBT ÷ Revenue
= 100 × 184,665 ÷ 730,230 = 25.29%

4 Click competitor name to see calculations.

Profitability ratio Description The company
OPM The operating profit margin (OPM) is the ratio of pretax economic earnings, or NOPBT, to sales. Shockwave Medical Inc. OPM improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023.

Turnover of Capital (TO)

Shockwave Medical Inc., TO calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in thousands)
Revenue 730,230 489,733 237,146 67,789 42,927
Invested capital1 672,462 318,057 174,255 91,274 158,673
Efficiency Ratio
TO2 1.09 1.54 1.36 0.74 0.27
Benchmarks
TO, Competitors3
Abbott Laboratories 0.67 0.71 0.69 0.57 0.55
Cigna Group 2.26 2.09 1.90 1.70 1.62
CVS Health Corp. 2.64 2.60 2.22 1.96 1.83
Elevance Health Inc. 2.44 2.33 2.14 2.13 1.86
Humana Inc. 3.48 3.18 2.70 3.48 3.41
Intuitive Surgical Inc. 1.00 1.16 1.27 0.98 1.35
Medtronic PLC 0.44 0.46 0.42 0.41 0.42
UnitedHealth Group Inc. 2.01 1.95 2.04 1.96 2.05

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Invested capital. See details »

2 2023 Calculation
TO = Revenue ÷ Invested capital
= 730,230 ÷ 672,462 = 1.09

3 Click competitor name to see calculations.

Efficiency ratio Description The company
TO The turnover of capital (TO) is the ratio of sales to invested capital. Capital turnover is a function of the efficiency of working capital management and of net fixed assets. Shockwave Medical Inc. TO improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023.

Effective Cash Tax Rate (CTR)

Shockwave Medical Inc., CTR calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in thousands)
Net operating profit after taxes (NOPAT)1 170,498 122,053 (7,113) (64,111) (49,755)
Add: Cash operating taxes2 14,167 2,898 847 453 390
Net operating profit before taxes (NOPBT) 184,665 124,951 (6,266) (63,658) (49,365)
Tax Rate
CTR3 7.67% 2.32%
Benchmarks
CTR, Competitors4
Abbott Laboratories 21.67% 23.97% 20.05% 12.92% 21.15%
Cigna Group 30.27% 24.44% 23.01% 24.93% 25.68%
CVS Health Corp. 29.07% 50.90% 27.09% 29.36% 30.33%
Elevance Health Inc. 28.75% 22.11% 20.37% 32.42% 18.95%
Humana Inc. 28.91% 23.74% 14.62% 23.28% 17.80%
Intuitive Surgical Inc. 20.94% 27.40% 11.76% 6.67% 8.23%
Medtronic PLC 32.28% 19.53% 18.59% 14.72% 19.30%
UnitedHealth Group Inc. 20.64% 23.25% 20.32% 22.88% 19.29%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2023 Calculation
CTR = 100 × Cash operating taxes ÷ NOPBT
= 100 × 14,167 ÷ 184,665 = 7.67%

4 Click competitor name to see calculations.